Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
←Back to story

FDA Approves Klygefa for Weekly Myasthenia Gravis Self-Injection; Meningococcal Warning Unconfirmed

Tech TimesView source article

Part of story

FDA approves Regeneron drug for generalized myasthenia gravis

The FDA approved Regeneron Pharmaceuticals' drug to treat adults with generalized myasthenia gravis, a rare autoimmune disease.

Nov 18, 2026·4 sourcesFDA drug approvalRisk evaluation & mitigation (REMS)Drug Policy, Pricing & ApprovalClinical trialsRare diseasesAutoimmune diseaseEuropean Union
FDA approves Regeneron drug for generalized myasthenia gravis
00

Other sources for this story

The American Journal of Managed Care

FDA Approves Weekly Gefurulimab for Generalized Myasthenia Gravis | AJMC

BioSpace

Livsayis™ (cemdisiran) Approved by the FDA as First and Only siRNA Therapy in Generalized Myasthenia Gravis and Only Treatment with Four-Times-a-Year Subcutaneous Dosing - BioSpace

Reuters

US FDA approves Regeneron's drug for generalized myasthenia gravis | Reuters